AFT Pharmaceuticals Ltd. (AU:AFP) has released an update.
AFT Pharmaceuticals has announced a partnership with Alexso to distribute its non-opioid pain management product, Maxigesic Rapid, in the U.S. market. This move represents the launch of AFT’s second patented pharmaceutical product in the U.S., with further negotiations underway to expand distribution channels. The partnership is aligned with Alexso’s commitment to providing effective alternatives to opioids for pain management.
For further insights into AU:AFP stock, check out TipRanks’ Stock Analysis page.
